Yourgene® DPYD Genotyping Assay
Fluoropyrimidine Chemotherapy Toxicity Risk
CommercialActive
Key Facts
About Novacyt
Novacyt is a publicly traded molecular diagnostics company with a mission to be a trusted provider enabled by technical expertise, innovation, and global partnerships. The company has achieved significant scale and diversification through strategic acquisitions, including Primerdesign, Yourgene Health, and Southern Cross Diagnostics, creating an integrated business model spanning R&D, manufacturing, and global distribution. Its strategy focuses on leveraging its multi-brand portfolio to deliver end-to-end solutions in high-growth areas like reproductive health, precision medicine, and infectious disease.
View full company profile